Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
COVID-19
Ohio State University
Ohio State University Tumor Boards
Questions discussed in this category
How long should breast cancer patients whose surgeries are delayed due to COVID-19 remain on neoadjuvant endocrine therapy?
For patients with low risk, early stage, HR+/HER2- breast cancer who initiated endocrine therapy in order to delay their surgery due to the COVID 19 e...
3 Answers available
7062
Related Topics in COVID-19
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Gastrointestinal Cancers
Genitourinary Cancers
Melanoma/Skin Cancer
Non-malignant Disease
Pediatric Hematology/Oncology
